when will eli lilly release retatrutide Strengthens Its Weight Loss Pipeline. Why Could Be the Next Growth Driver for LLY Weight Loss: Lilly's New Drug

These side effects are generally mild to moderate and tend to diminish over time as the body adjusts to the medication

A 2025 survey of Canadian private insurers by the Conference Board of Canada found: 34% of employer-sponsored plans cover Wegovy with prior authorization 18% cover it without restrictions beyond a BMI threshold 48% exclude all obesity medications from formulary Average patient copay when covered: 20-30% after deductible Plans that cover Wegovy typically require: BMI threshold

It is not approved by the FDA and is not intended for diagnosis, treatment, prevention, or therapeutic use

Biol Reprod 2003

It can also be taken in supplement form